Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 4:32 pm Purchase | 2024-11-30 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 40,451,057 10.400% | 7,599,584 (+23.13%) | Filing History |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | DexCom, Inc. DXCM | VANGUARD GROUP INC | 44,467,151 11.510% | 647,315 (+1.48%) | Filing History |
| 2024-01-25 1:48 pm Sale | 2023-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 32,851,473 8.500% | -684,207 (-2.04%) | Filing History |
| 2023-02-10 4:22 pm Sale | 2022-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 33,535,680 8.700% | -347,000 (-1.02%) | Filing History |
| 2023-02-09 11:16 am Purchase | 2022-12-30 | 13G | DexCom, Inc. DXCM | VANGUARD GROUP INC | 43,819,836 11.340% | 2,178,560 (+5.23%) | Filing History |
| 2023-01-27 2:36 pm Unchanged | 2022-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 33,882,680 8.700% | 0 (Unchanged) | Filing History |
| 2023-01-25 10:36 am Purchase | 2022-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 33,882,680 8.800% | 1,368,864 (+4.21%) | Filing History |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | DexCom, Inc. DXCM | VANGUARD GROUP INC | 41,641,276 10.740% | 712,296 (+1.74%) | Filing History |
| 2022-02-09 09:11 am Sale | 2022-02-08 | 13G | DexCom, Inc. DXCM | FMR LLC | 18,464,700 4.759% | -9,778,712 (-34.62%) | Filing History |
| 2022-02-08 5:12 pm Purchase | 2021-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 32,513,816 8.400% | 4,480,524 (+15.98%) | Filing History |
| 2021-12-06 09:35 am Sale | 2021-11-30 | 13G | DexCom, Inc. DXCM | BAILLIE GIFFORD & CO | 18,801,520 4.850% | -3,013,856 (-13.82%) | Filing History |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | DexCom, Inc. DXCM | T. Rowe Price Associates, Inc. | 8,557,216 2.200% | -9,771,056 (-53.31%) | Filing History |
| 2021-02-10 10:46 am Sale | 2020-12-31 | 13G | DexCom, Inc. DXCM | VANGUARD GROUP INC | 40,928,980 10.660% | -690,716 (-1.66%) | Filing History |
| 2021-02-08 10:19 am Sale | 2021-02-05 | 13G | DexCom, Inc. DXCM | FMR LLC | 28,243,412 7.346% | -512,040 (-1.78%) | Filing History |
| 2021-02-05 07:51 am Purchase | 2020-12-31 | 13G | DexCom, Inc. DXCM | BlackRock Inc. BLK | 28,033,292 7.300% | 6,040,672 (+27.47%) | Filing History |
| 2021-01-14 12:06 pm Purchase | 2020-12-31 | 13G | DexCom, Inc. DXCM | BAILLIE GIFFORD & CO | 21,815,376 5.680% | 3,668,384 (+20.21%) | Filing History |
| 2020-06-10 10:24 am Purchase | 2020-05-29 | 13G | DexCom, Inc. DXCM | VANGUARD GROUP INC | 41,619,696 11.270% | 7,750,756 (+22.88%) | Filing History |
| 2020-05-04 10:27 am Sale | 2020-04-30 | 13G | DexCom, Inc. DXCM | BAILLIE GIFFORD & CO | 18,146,992 4.910% | -1,114,204 (-5.78%) | Filing History |